Phage Therapy Experience at the Eliava Phage Therapy Center: Three Cases of Bacterial Persistence

被引:32
|
作者
Zaldastanishvili, Elisabed [1 ]
Leshkasheli, Lika [1 ]
Dadiani, Mariam [2 ]
Nadareishvili, Lia [2 ]
Askilashvili, Lia [1 ]
Kvatadze, Nino [3 ]
Goderdzishvili, Marina [3 ]
Kutateladze, Mzia [4 ]
Balarjishvili, Nana [1 ]
机构
[1] Eliava Inst Bacteriophages Microbiol & Virol, Lab Mol Biol, Tbilisi 0160, Georgia
[2] Eliava Phage Therapy Ctr EPTC, Tbilisi 0160, Georgia
[3] Eliava Inst Bacteriophages Microbiol & Virol, Lab Gen Microbiol, Tbilisi 0160, Georgia
[4] Eliava Inst Bacteriophages Microbiol & Virol, Tbilisi 0160, Georgia
来源
VIRUSES-BASEL | 2021年 / 13卷 / 10期
关键词
phage therapy; Pseudomonas aeruginosa; Klebsiella pneumoniae;
D O I
10.3390/v13101901
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this retrospective descriptive study we focus on cases of three patients who underwent phage therapy procedures at Eliava Phage Therapy Center (EPTC) in Tbilisi, Georgia. Patients with chronic infectious diseases related to Pseudomonas aeruginosa (two patients, lower respiratory tract infection (LRTI)) and Klebsiella pneumoniae (one patient, urinary tract infection (UTI)) are among those very few EPTC patients whose pathogens persisted through phage therapy. By looking at bacterial strains and personalized phages used against them we tried to point towards possible adaptation strategies that are employed by these pathogens. Genome restriction-based Pulsed Field Gel Electrophoresis (PFGE) profiling of strains isolated before and after phage therapy hints towards two strategies of adaptation. In one patient case (Pseudomonas aeruginosa related lung infection) bacterial strains before and after phage therapy were indistinguishable according to their PFGE profiles, but differed in their phage susceptibility properties. On the other hand, in two other patient cases (Pseudomonas aeruginosa related LRTI and Klebsiella pneumoniae related UTI) bacterial adaptation strategy seemed to have resulted in diversification of infecting strains of the same species. With this work we want to attract more attention to phage resistance in general as well as to its role in phage therapy.</p>
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Phage therapy: A modern tool to control bacterial infections
    Qadir, Muhammad Imran
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 28 (01) : 265 - 270
  • [32] Phage Therapy for Antibiotic-Resistant Bacterial Infections
    Hatfull, Graham F.
    Dedrick, Rebekah M.
    Schooley, Robert T.
    ANNUAL REVIEW OF MEDICINE, 2022, 73 : 197 - 211
  • [33] Perspectives of Phage Therapy in Non-bacterial Infections
    Gorski, Andrzej
    Bollyky, Paul L.
    Przybylski, Maciej
    Borysowski, Jan
    Miedzybrodzki, Ryszard
    Jonczyk-Matysiak, Ewa
    Weber-Dabrowska, Beata
    FRONTIERS IN MICROBIOLOGY, 2019, 9
  • [34] Models of phage growth and their applicability to phage therapy
    Weld, RJ
    Butts, C
    Heinemann, JA
    JOURNAL OF THEORETICAL BIOLOGY, 2004, 227 (01) : 1 - 11
  • [35] Phage Choice, Isolation, and Preparation for Phage Therapy
    Gill, Jason J.
    Hyman, Paul
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2010, 11 (01) : 2 - 14
  • [36] Phage Therapy: A Different Approach to Fight Bacterial Infections
    Hibstu, Zigale
    Belew, Habtamu
    Akelew, Yibeltal
    Mengist, Hylemariam Mihiretie
    BIOLOGICS-TARGETS & THERAPY, 2022, 16 : 173 - 186
  • [37] The perspectives of the application of phage therapy in chronic bacterial prostatitis
    Letkiewicz, Slawomir
    Miedzybrodzki, Ryszard
    Klak, Marlena
    Jonczyk, Ewa
    Weber-Dabrowska, Beata
    Gorski, Andrzej
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2010, 60 (02): : 99 - 112
  • [38] Phage therapy for severe bacterial infections: a narrative review
    Fabijan, Aleksandra Petrovic
    Khalid, Ali
    Maddocks, Susan
    Ho, Josephine
    Gilbey, Timothy
    Sandaradura, Indy
    Lin, Ruby C. Y.
    Ben Zakour, Nouri
    Venturini, Carola
    Bowring, Bethany
    Iredell, Jonathan R.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (06) : 279 - +
  • [39] Phage therapy and phage control: to be revisited urgently!!
    Vandamme, Erick J.
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2014, 89 (03) : 329 - 333
  • [40] PREDICTING HOW BACTERIAL PATHOGENS RESPOND TO PHAGE THERAPY
    Turner, P. E.
    Kortright, K. E.
    Chan, B.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S179 - S179